BDNF and treatment resistant depression: Adding to this complexity, a study comparing serum BDNF levels in TRD patients treated with intravenous ketamine (0.5 mg/kg) or esketamine (0.25 mg/kg) found no significant differences at baseline, 24 h, or 72 h post-treatment [20].